Congestion is a cardinal sign of heart failure (HF). In the past, it was seen as a
homogeneous epiphenomenon that identified patients with advanced HF. However, current …

Natriuretic peptides, brain (B-type) natriuretic peptide (BNP) and N-terminal prohormone of
brain natriuretic peptide (NT-proBNP) are globally and most often used for the diagnosis of …

Congestion explains many of the signs and symptoms of acute heart failure (AHF) and
disease progression. However, accurate quantification of congestion is challenging in daily …

Interest in the pathophysiology, etiology, management, and outcomes of patients with
tricuspid regurgitation (TR) has grown in the wake of multiple natural history studies showing …

Increasing evidence suggests a multifaceted relationship exists between cancer and
cardiovascular disease (CVD). Here, we introduce a 5-tier classification system to categorize …

Right‐sided heart failure and tricuspid regurgitation are common and strongly associated
with poor quality of life and an increased risk of heart failure hospitalizations and death …

Background Elevated circulating carbohydrate antigen 125 (CA125) is a marker of
congestion and a predictor of outcomes in acute heart failure (HF). Less is known about …

Congestion is the permanent mechanism driving disease progression in patients with acute
heart failure (AHF) and also is an important treatment target. However, distinguishing …

Background This study aimed to evaluate whether glomerular filtration rate (eGFR) during
admission modifies the predictive value of plasma amino-terminal pro-brain natriuretic …

Aim Vascular congestion may lead to an increase of carbohydrate antigen 125 (CA‐125).
The role of CA‐125 as a biomarker of congestion or for prognosis across the full ejection …